Cipla recebe aprovação final para versão genérica do IMITREX® da GlaxoSmithKline (Spray Nasal Sumatriptan, 20 mg) ...Middle East

MUMBAI, Índia, 3 de março de 2021 /PRNewswire/ -- A Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (doravante denominada "Cipla") anunciou hoje que recebeu aprovação final para seu Pedido Abreviado de Novo Medicamento (ANDA - Abbreviated New Drug Application) para o Spray Nasal Sumatriptan,...

Hence then, the article about cipla recebe aprovacao final para versao generica do imitrex da glaxosmithkline spray nasal sumatriptan 20 mg was published today ( Wednesday 03/03/2021 - 06:46 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cipla recebe aprovação final para versão genérica do IMITREX® da GlaxoSmithKline (Spray Nasal Sumatriptan, 20 mg) )

Also on site :

• Chappell Roan’s ‘Call Her Daddy’ Episode, KATSEYE, Young Miko & More Win at 2026 GLAAD Media Awards: Full Winners List
• Utility poles and trees fall across the area after freezing rain
• Cost to US for war on Iran is $3.7bn in first 100 hours, says think tank